Studies have repeatedly demonstrated that sensitization to fungi, such as *Alternaria*, is strongly associated with allergic rhinitis and asthma in children ([@b2-ehp0113-001405]; [@b13-ehp0113-001405]; [@b18-ehp0113-001405]; [@b28-ehp0113-001405]). However, the role of exposure to fungi, measured in environmental samples, in the development of childhood allergic rhinitis is poorly understood. Allergic rhinitis affects an estimated 20--40 million people in the United States alone, and the incidence is increasing. Allergic rhinitis has been associated with snoring, sleep apnea, and sleep disturbances in children ([@b4-ehp0113-001405]; [@b9-ehp0113-001405]; [@b31-ehp0113-001405]). The prevalence of symptoms of allergic rhinoconjunctivitis ranged between 15 and 25% among children 13--14 years of age who lived in the United States or the United Kingdom ([@b20-ehp0113-001405]). A recent study documented that 93% of adolescents with allergic asthma also have allergic rhinitis. The diagnosis of allergic rhinitis preceded asthma in up to 64% of patients with both diseases ([@b23-ehp0113-001405]). Because allergic rhinitis is a common disease that lessens quality of life and is associated with significant morbidity, determining environmental exposures associated with the development of allergic rhinitis is of great public health importance.

In a prospective birth-cohort study of children with parental history of asthma or allergies, we assessed environmental fungal exposure (culturable fungi in house air and dust samples) and evaluated whether high fungal levels were independently associated with doctor-diagnosed allergic rhinitis in the first 5 years of life.

Materials and Methods
=====================

Study protocol.
---------------

Participants were part of a metropolitan Boston, Massachusetts, prospective birth-cohort study designed to examine relationships between amounts of indoor allergens, including fungi, and the development of allergy and asthma. The study was approved by the institutional review board of Brigham and Women's Hospital. With the consent of the primary caregiver, screening and recruitment of the families, which we have previously described ([@b16-ehp0113-001405]), was conducted between September 1994 and June 1996. Monday through Friday, all mothers who delivered at Brigham and Women's Hospital, a large Boston hospital, were approached for screening within 24--48 hr after delivery. Eligibility criteria included residence inside route 128 (a highway encircling the Boston metropolitan area); maternal age ≥18 years; history of hay fever, asthma, or allergies in either parent; and maternal ability to speak English or Spanish. Families were not screened if the newborn was hospitalized in the intensive care unit, was of gestational age \< 36 weeks, or had a congenital anomaly. One month after birth, a questionnaire regarding the child's health was administered by telephone to families who had initially expressed interest in participating in the study and who fit the inclusion criteria. At 1 month, parents who expressed plans to move or lack of interest in the study were also excluded. Of the 1,405 families screened, 906 were excluded from the study before the initial home visit. Reasons for exclusion were reluctance to participate in a longitudinal study (51%), plans to move within 1 year (39%), early loss to follow-up (9%), and other (1%). After written informed consent was obtained, a home visit was made when the child was 2--3 months of age, and a questionnaire regarding health outcomes, home characteristics, environmental exposures, smoking, and demographics was administered by trained research assistants. Every 2 months, beginning when the child was 2 months old and continuing until the second birthday, a telephone questionnaire was administered to the child's primary caretaker. After that, health outcomes were ascertained semiannually.

At the initial home visit, indoor air samples were collected from each home using a Burkard culture plate sampler (Burkard Manufacturing Co. Ltd., Hertfordshire, UK) operated at 45 L/min \[calculated cut point, diameter allowing 50% (D~50~) = 2 μm\] that collected particles onto DG18 agar (a glucose medium containing dichloran and 18% glycerol) in 90-mm Petri dishes. Sequential duplicate 1-min air samples were collected in the bedroom 1--1.5 m above the area of the floor demarcated for dust collection. After sampling, the Petri plates were returned to the laboratory on the same day for incubation. The sampler sieve plate was cleaned with an isopropanol swab after each home visit.

After air samples were collected, 2 m^2^ of the floor surrounding the newborn's bed was vacuumed for 5 min, using a Eureka Mighty-Mite canister vacuum cleaner (Eureka Co., Bloomington, IN) modified to collect dust in a 19- × 90-mm cellulose extraction thimble (Whatman International Ltd., Herefordshire, UK). In cases where both a smooth floor and a rug were present, 2.5 min was devoted to sampling the rug and 2.5 min was spent vacuuming the smooth floor surface. After sampling, the thimble was sealed in a plastic bag and returned to the laboratory for sifting (425-μm mesh sieve) and weighing.

A weighed aliquot of fine dust from the dust sampling was suspended (\~ 25 mg/mL) and serially diluted (e.g., full strength, 1:10, and 1:100) in an aqueous solution of 0.02% Tween. Duplicates of each dilution were spread-plated on DG18 culture media ([@b37-ehp0113-001405]). After a mean ± SD incubation period of 27.9 ± 14.5 days, we identified fungal colonies on both air- and dust-sample plates to genus (subgenus in the case of *Aspergillus* isolates) using standard mycologic criteria ([@b14-ehp0113-001405]; [@b38-ehp0113-001405]). We adjusted the number of colonies recovered on the air sample plates for possible multiple impactions using the positive-hole correction equation ([@b1-ehp0113-001405]). The calculated concentrations of dust-borne fungi were the number of colony-forming units (cfu) per gram of dust, and those of airborne fungi were cfu per cubic meter of air. We prioritized the use of limited amounts of dust collected from a home so that measurement of allergens for cockroach, cat, and dust mites could be performed first ([@b6-ehp0113-001405]), followed by analyses of fungi and endotoxin, respectively. If there was not enough dust for allergen analyses, then the fungal analyses were performed first. Thus, when there was \> 200 mg or \< 25 mg dust collected, fungal concentrations were determined. There were 84 children eliminated because the amount of dust collected was between 25 and 200 mg.

Fungal data.
------------

In previous analyses of these data ([@b34-ehp0113-001405]), we found that it was useful to create indices indicating high levels of fungi in the home. The variable was coded 1 if that home produced "high" levels of that fungus, and 0 otherwise. We define "high" as greater than the 90th percentile for each taxon. Based on Akaike's Information Criterion ([@b19-ehp0113-001405]) and --2 log likelihood, models with indices for high fungal levels fit the data better than do models treating the fungal concentrations as continuous or natural logarithm--transformed data.

Definition of allergic rhinitis and predictor variables.
--------------------------------------------------------

We assessed allergic rhinitis from 12 to 60 months of age by asking "Has your child had allergic rhinitis or hay fever diagnosed by a doctor?" Children without 12-month follow-up (*n* = 10) were excluded, leaving 405 children with \> 12 months of health outcome data, as well as fungal data.

Definitions of other predictor variables.
-----------------------------------------

Sociodemographic, familial, and perinatal variables considered for inclusion in the multivariate analysis of the relation between indoor fungal exposure and allergic rhinitis included sex, season of birth \[defined as winter (December--February), spring (March--May), summer (June--August), or fall (September--November)\], race/ethnicity of the child according to parental reporting ([@b25-ehp0113-001405]), total annual family income (\< \$30,000, \$30,000--50,000, and \> \$50,000), active maternal history of asthma (physician-diagnosed asthma and wheeze in the past year), maternal sensitization to *Alternaria* \[specific immunoglobulin E (IgE) \> 0.35 U/mL\], maternal smoking during pregnancy, and presence of older siblings in the household.

Additional variables considered for inclusion in the multivariate analysis included report of any of the following in the child's first year of life: any physician-diagnosed lower respiratory tract infections (pneumonia, croup, bronchitis, or bronchiolitis), as determined by bimonthly questions to the child's primary caregiver ([@b5-ehp0113-001405]); visible water damage; mold or mildew inside the home; and report of water damage in the basement, presence of concrete floors in the baby's room, use of a dehumidifier, and use of an air conditioner. A composite variable representing the presence of either water damage or visible mold or mildew in the home in the child's first year of life was also examined.

Statistical methods.
--------------------

All final models reported used survival analysis (Cox proportional hazards regression) to explore time to first report of doctor-diagnosed allergic rhinitis or hay fever. We performed initial exploratory analyses of univariate associations between allergic rhinitis and potential predictor variables using logistic regression, chi-square analyses, and Cox regression. We performed all statistical analyses using SAS statistical software (version 8.2, SAS Institute Inc., Cary, NC) and S-Plus (version 6.1, Insightful Corporation, Seattle, WA). Multivariate models were constructed that included significant (*p* ≤0.05) fungal taxa, significant independent predictors of allergic rhinitis, and variables that may confound the relationship between the fungal levels and allergic rhinitis. The proportional hazards assumption was validated in final models.

Lasso approach.
---------------

Multivariate models were independently validated using the lasso approach for model shrinkage described by [@b36-ehp0113-001405]. This technique prevents the tendency to overfit a model by constraining the effect that the variables will have in the model. This is one approach used to combat the multiple-comparison hazards that arise when so many different taxa of fungi need to be considered.

Results
=======

Of the 405 children included in this analysis, 52 (12.8%) were diagnosed with allergic rhinitis or hay fever by a doctor before or at 5 years of age.

Relationship between cohort characteristics and allergic rhinitis.
------------------------------------------------------------------

[Table 1](#t1-ehp0113-001405){ref-type="table"} shows the relationship between cohort characteristics and doctor-diagnosed allergic rhinitis by 5 years of age. Factors associated with an increased risk of allergic rhinitis included African-American ethnicity, being born between September and November, maternal sensitization to *Alternaria* (IgE to *Alternaria* \> 0.35 U/mL), and having at least one lower respiratory tract illness in the first year of life. Male sex and water damage or mold or mildew in the building of residence within the first year of life were marginally associated with doctor-diagnosed allergic rhinitis by 5 years of age.

In [Table 2](#t2-ehp0113-001405){ref-type="table"}, we report the number of houses from which each taxon was cultured, and the value corresponding to the 90th percentile. Penicillium was the most common taxon sampled from the air, but Cladosporium, Penicillium, and nonsporulating fungi had the highest levels recovered from the air. From the dust samples, Aspergillus was most commonly recovered sporulating taxon, followed by Cladosporium.

High levels of dust-borne Aureobasidium, Aspergillus, Alternaria, yeasts, and nonsporulating fungi as well as high levels of total fungi were independently associated with the development of doctor-diagnosed allergic rhinitis by 5 years of age in analyses controlling for factors significantly associated with allergic rhinitis ([Table 3](#t3-ehp0113-001405){ref-type="table"}). These factors included water damage or mold or mildew in the building during the first year of the child's life, any lower respiratory tract illness in the first year, male sex, African-American race, birth date between September and November, and maternal IgE to Alternaria \> 0.35 U/mL.

In a multivariate adjusted proportional hazards regression analysis looking simultaneously at the effects of high fungal levels and significant independent predictors ([Table 4](#t4-ehp0113-001405){ref-type="table"}), dust-borne Aspergillus \[hazard ratio (HR) = 3.27; 95% confidence interval (CI), 1.50--7.14\], Aureobasidium (HR = 3.04; 95% CI, 1.33--6.93), and yeasts (HR = 2.67; 95% CI, 1.26--5.66) remained significantly associated with allergic rhinitis. Alternaria and Cladosporium were not significant in the multivariate model, because they are highly correlated with other fungi that were significant. Alternaria was significantly correlated with Aureobasidium (R = 0.33, p \< 0.0001) to the point where its contribution to the model is not statistically significant after considering the effect of Aureobasidium. When Aureobasidium is omitted from the model ([Table 4](#t4-ehp0113-001405){ref-type="table"}, model 3), Alternaria is borderline significant (HR = 2.07; 95% CI, 0.98--4.37). Alternaria and Cladosporium were highly correlated as well (R = 0.30, p \< 0.0001). Having high levels of total dust-borne fungi was not significant in multivariate models that had the specific taxa listed above (p = 0.44). The magnitude and strength of these associations remained essentially unchanged when controlling for the presence of dust mite, cockroach, and cat allergens and endotoxin in the home, none of which had significant independent associations with allergic rhinitis by age 5 in multivariate models (data not shown).

Discussion
==========

High dust-borne fungal levels of Alternaria, Aspergillus, Aureobasidium, and yeasts measured in the home in the first 3 months of life were associated with the subsequent development of doctor-diagnosed allergic rhinitis within the first 5 years of life, independent of water damage or mold or mildew in the home, race, sex, season of birth, lower respiratory tract infection in the first year of life, and maternal IgE to Alternaria \> 0.35 U/mL. Home dampness has been shown to be related to allergic rhinitis exacerbations ([@b24-ehp0113-001405]), but to our knowledge, the relation of either water damage or mold/mildew or high levels of specific fungal taxa to the development of allergic rhinitis in childhood has not previously been reported.

Although other studies have found associations between measures of total fungi and health outcomes ([@b15-ehp0113-001405]), it is likely that, in our study, "total fungi" is a noisier estimate of relevant fungal exposures than are our other metrics of fungi. The measure of "total fungi" would combine fungi not likely to be related to rhinitis along with fungi that have been identified as being related to allergic sensitization. This could lead to less precise estimates of fungal heath effects and an attenuation of the relationship between fungi and allergic rhinitis.

Fungal exposure is complex. Fungi can contain allergens, irritants, toxins, and sometimes even potentially infectious units ([@b22-ehp0113-001405]). (1→3)-β-[d]{.smallcaps}-Glucans---glucose polymers that are structural components of most fungal cell walls---are known to stimulate macrophages and neutrophils and have been shown to be good markers for the overall levels of fungal concentrations in floor dust ([@b7-ehp0113-001405]). [@b3-ehp0113-001405] found that an inhalation challenge to (1→3)-β-[d]{.smallcaps}-glucans has an effect on the inflammatory cells, which may be related to chronic exposure to household molds. Fungi are ubiquitous, and exposure is impossible to completely avoid. Often, there are no adverse effects from these exposures ([@b26-ehp0113-001405]), but at times exposure to fungi can directly and indirectly influence an individual's health. Fungal exposure in sensitized individuals may result in histamine and IgE-mediated nasal inflammation ([@b33-ehp0113-001405]). Chronic exposure to fungi may also cause chronic nasal symptoms that are not allergic in nature, but rather caused by irritants ([@b10-ehp0113-001405]; [@b12-ehp0113-001405]). Symptoms of allergic rhinitis are similar to the chronic nasal symptoms often found with sick building syndrome. Given that fungi may play a role in sick building syndrome as well ([@b32-ehp0113-001405]), differentiation may be difficult.

In previous articles we have reported that endotoxin was a risk factor for wheeze ([@b29-ehp0113-001405]) yet had a protective effect on eczema in the first year of life ([@b30-ehp0113-001405]). However, the associations of fungi with allergic rhinitis remained essentially unchanged when controlling for the presence of indoor allergens and endotoxin.

There is a large literature demonstrating the relationship between fungal sensitization and allergic rhinitis and asthma, as well as a growing literature linking fungal exposure to asthma and rhinitis exacerbation ([@b13-ehp0113-001405]; [@b18-ehp0113-001405]) in sensitized children ([@b2-ehp0113-001405]; [@b28-ehp0113-001405]). However, the fact that children with allergic rhinitis are sensitized to fungi does not necessarily mean that fungal exposure will lead to allergy or allergic symptoms. This study suggests a prospective relationship between exposure and symptoms, although elevation of the individual fungal taxa may not lead directly to symptom development. For example, relative elevation of specific taxa such as Aspergillus, Aureobasidium, and yeasts may be a marker for overall fungal exposure. In models containing the individual taxa and our measure of total fungi, total fungi was not predictive of allergic rhinitis, suggesting that the combination of individual taxa was a better marker of clinically relevant fungal exposure.

Sensitization to Alternaria, Aspergillus, and Penicillium allergens have been suggested as being related to allergic rhinitis and asthma exacerbation in children ([@b8-ehp0113-001405]; [@b18-ehp0113-001405]). Purified and characterized allergens have been prepared for Aspergillus fumigatus (Asp f 1 and Asp f 3) ([@b26-ehp0113-001405]), which has been shown to cause skin reactivity in patients with allergic rhinitis ([@b22-ehp0113-001405]). However, A. fumigatus was sampled from only three houses. The most commonly sampled species in this cohort were members of the Aspergillus glaucus group (n = 275) and Aspergillus versicolor (n = 255). Although skin test material is commonly available for both, less is known about the allergenicity of these species. A. versicolor has been implicated in an outbreak of allergic respiratory disease ([@b21-ehp0113-001405]).

Cladosporium and Alternaria are known sources of allergens, including the proteins Alt a 1, Alt a 2, and Cla h 1 ([@b22-ehp0113-001405]). Many cross-sectional studies have correlated Cladosporium and Alternaria sensitization with diagnoses of asthma, eczema, and rhinitis ([@b2-ehp0113-001405]; [@b13-ehp0113-001405]; [@b18-ehp0113-001405]; [@b28-ehp0113-001405]).

Aureobasidium has been associated with hypersensitivity pneumonitis ([@b17-ehp0113-001405]), but its role in the development of allergic rhinitis is unknown. In this study, it may be a marker for mold in the home, rather than the actual source of the chronic nasal symptoms.

In their association with chronic nasal symptoms, yeasts may also be a marker for overall mold exposure, because although they have known associations with skin manifestations of allergy, nasal symptoms are less commonly documented. Yeasts are unicellular fungi that reproduce primarily by budding and, in culture, form pasty colonies similar to those of bacteria ([@b26-ehp0113-001405]). Several studies have shown that patients with atopic dermatitis and respiratory allergy often develop IgE antibodies against yeasts ([@b11-ehp0113-001405]; [@b27-ehp0113-001405]; [@b35-ehp0113-001405]). One showed that patients with atopic dermatitis of the head and neck developed IgE antibodies against the yeast Pityrosporum ovale much more often than did their control group. Another found that the enzyme enolase from baker's yeast (Saccharomyces cerevisiae) induces an immediate dermal allergic reaction in subjects with respiratory allergy and positive skin tests to Candida albicans and other fungi. A third group demonstrated that Pityrosporum orbiculare can induce an eczematous reaction in sensitized atopic dermatitis patients.

Potential study limitations.
----------------------------

This study does have some limitations. Potential limitations of our work include the relatively small sample size, along with the multiplicity of variables being considered. Our use of the Lasso approach provides an efficient and appealing method for handling multiplicity issues. The Lasso method is much less prone to missing real associations than more traditional adjustments for multiple comparisons, such as Bonferroni. Even so, the reality is that with only 52 cases, some important differences may have been missed. It is unlikely, however, that our analysis erroneously identified many false associations, if any. In addition, because of the collinearity of the fungal data and the paucity of events, it is difficult to assess the risk of each taxon controlling for the others. For example, Alternaria is so significantly correlated with Aureobasidium that its effect is masked when both are included in the model. Even still, in a combined multivariate model, high levels of Aspergillus, Aureobasidium, and yeasts were independently associated with an increased risk of doctor-diagnosed allergic rhinitis within the first 5 years of life. In addition, the air and dust samples were single, short-term samples. Therefore, it is not clear how representative the samples are of long-term household fungal levels. We used only a culture-based analysis to determine fungal concentrations, which would underestimate actual fungal spore exposures and does not account for other fungal agents. Also, the culture media used for both the air and dust samples, DG18, has high solute concentration, which limits the amount of available water. Thus, some strongly hydrophilic fungi (e.g., Stachybotrys sp., some yeasts) might be underrepresented. In addition, all relationships discussed in this article are related to exposures that occurred in the first home in which the child lived, and do not account for conditions in any subsequent homes or locations where the child may have spent significant time (e.g., a child care center). Moreover, without sampling performed throughout the study ([@b7-ehp0113-001405]), it is impossible to determine whether high fungal levels early in life increase the likelihood of having doctor-diagnosed allergic rhinitis later in life, or whether the early sampling is representative of the environment later in life. In addition, the absence of definitive measurements of allergy, and the relatively early age of ascertainment of outcome in this study such that some children may yet develop allergic rhinitis in this cohort, may be responsible for the lack of an endotoxin effect on the risk of allergic rhinitis in this analysis. Further, parental report of allergic rhinitis or hay fever was not confirmed by chart review, but primary care physician documentation of these diagnoses may not be the gold standard because it is likely to vary by individual practice. In addition, it is possible that the parents did not understand or recall a diagnosis of allergic rhinitis. Lastly, without skin-prick testing, the possibility exists that nasal symptoms related to chronic irritation were misdiagnosed as allergic rhinitis by the physicians of some of the participating children. Even if fungal exposure in infancy leads to allergic rhinitis in some children and to chronic irritant nonallergic rhinitis in others, these findings still have important public health implications.

Conclusions
===========

Recently, more attention has been given to the need for monitoring of fungal levels and active intervention, where necessary ([@b22-ehp0113-001405]). Epidemiologic studies have found associations between report of home dampness and respiratory symptoms in early life, but most have not measured fungi directly and have not determined whether fungal effects can be distinguished from other exposures related to dampness that prospectively predict respiratory disease. Independent of early life report of home dampness, we found that specific dust-borne fungi measurable in the home in the first 3 months of a child's life was associated with an increased risk of developing doctor-diagnosed allergic rhinitis by 5 years of age.
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###### 

Cohort characteristics as predictors of allergic rhinitis.

  Factor                                    No.   Percent with allergic rhinitis   HR                                                      95% CI
  ----------------------------------------- ----- -------------------------------- ------------------------------------------------------- -------------
  Race/ethnicity                                                                                                                           
   White                                    309   12.0                                                                                     
   African American                         46    21.7                             2.22[\*](#tfn2-ehp0113-001405){ref-type="table-fn"}     1.10--4.47
   Hispanic                                 18    5.6                              0.53                                                    0.07--3.82
   Asian                                    26    15.4                             1.37                                                    0.49--3.85
   Other                                    6     0                                ---                                                     ---
  Season of birth                                                                                                                          
   Winter (December--February)              103   3.9                                                                                      
   Spring (March--May)                      112   12.5                             3.33[\*](#tfn2-ehp0113-001405){ref-type="table-fn"}     1.10--10.12
   Summer (June--August)                    87    13.8                             3.55[\*](#tfn2-ehp0113-001405){ref-type="table-fn"}     1.15--11.00
   Fall (September--November)               103   21.4                             5.76[\*\*](#tfn3-ehp0113-001405){ref-type="table-fn"}   1.99--16.72
  Sex of child                                                                                                                             
   Female                                   195   9.7                                                                                      
   Male                                     210   15.7                             1.64                                                    0.93--2.88
  Maternal IgE to Alternaria \> 0.35 U/mL                                                                                                  
   No                                       316   11.4                                                                                     
   Yes                                      43    25.6                             2.49[\*\*](#tfn3-ehp0113-001405){ref-type="table-fn"}   1.27--4.89
  Any LRI in year 1                                                                                                                        
   No                                       297   10.8                                                                                     
   Yes                                      108   18.5                             1.80[\*](#tfn2-ehp0113-001405){ref-type="table-fn"}     1.03--3.15
  Water damage in year 1                                                                                                                   
   No                                       263   11.0                                                                                     
   Yes                                      135   17.0                             1.59                                                    0.92--2.74
  Mold or mildew in year 1                                                                                                                 
   No                                       246   11.8                                                                                     
   Yes                                      152   15.1                             1.28                                                    0.74--2.22
  Water damage or mold                                                                                                                     
   No                                       169   10.1                                                                                     
   Yes                                      235   14.9                             1.46                                                    0.82--2.61

Abbreviations: ---, no data; LRI, lower respiratory infection.

p \< 0.05;

p \< 0.01.

###### 

Description of fungi included in the analysis.[a](#tfn4-ehp0113-001405){ref-type="table-fn"}

  Fungi                No. \> 0   90th percentile
  -------------------- ---------- -----------------
  Airborne (cfu/m3)               
   Aspergillus         253        100
   Cladosporium        315        400
   Nonsporulating      303        278
   Penicillium         346        189
   Yeasts              147        33
   Total airborne      402        1,044
  Dust-borne (cfu/g)              
   Alternaria          233        8,333
   Aspergillus         367        33,333
   Aureobasidium       322        24,000
   Cladosporium        343        33,088
   Coelomyces          93         2,941
   Fusarium            49         400
   Nonsporulating      373        38,889
   Penicillium         362        26,087
   Ulocladium          60         435
   Wallemia            61         1,429
   Yeasts              361        58,000
   Zygomycetes         57         909
   Total dust-borne    405        250,000

Must have been sampled from the indoor environment and have a 90th percentile \> 1 cfu.

###### 

Results of survival analysis of allergic rhinitis.

                       Unadjusted                                              Adjusted[a](#tfn5-ehp0113-001405){ref-type="table-fn"}                                                           
  -------------------- ------------------------------------------------------- -------------------------------------------------------- ------------------------------------------------------- ------------
  Airborne (cfu/m3)                                                                                                                                                                             
   Aspergillus         1.09                                                    0.44--2.75                                               1.10                                                    0.43--2.80
   Cladosporium        0.72                                                    0.26--2.00                                               1.25                                                    0.43--3.64
   Nonsporulating      0.54                                                    0.17--1.74                                               0.55                                                    0.17--1.81
   Penicillium         1.07                                                    0.42--2.68                                               0.69                                                    0.23--2.06
   Yeasts              0.98                                                    0.36--2.73                                               0.79                                                    0.24--2.60
   Total airborne      0.73                                                    0.27--2.04                                               0.83                                                    0.28--2.43
  Dust-borne (cfu/g)                                                                                                                                                                            
   Alternaria          2.50[\*\*](#tfn7-ehp0113-001405){ref-type="table-fn"}   1.28--4.86                                               2.34[\*](#tfn6-ehp0113-001405){ref-type="table-fn"}     1.12--4.91
   Aspergillus         2.47[\*\*](#tfn7-ehp0113-001405){ref-type="table-fn"}   1.27--4.81                                               2.57[\*](#tfn6-ehp0113-001405){ref-type="table-fn"}     1.22--5.40
   Aureobasidium       2.77[\*\*](#tfn7-ehp0113-001405){ref-type="table-fn"}   1.42--5.39                                               3.12[\*\*](#tfn7-ehp0113-001405){ref-type="table-fn"}   1.50--6.50
   Cladosporium        1.63                                                    0.77--3.46                                               1.88                                                    0.81--4.35
   Coelomyces          1.18                                                    0.51--2.77                                               0.93                                                    0.36--2.38
   Fusarium            1.25                                                    0.54--2.94                                               1.81                                                    0.76--4.34
   Nonsporulating      2.21[\*](#tfn6-ehp0113-001405){ref-type="table-fn"}     1.11--4.41                                               2.45[\*](#tfn6-ehp0113-001405){ref-type="table-fn"}     1.15--5.22
   Penicillium         1.34                                                    0.57--3.13                                               1.51                                                    0.63--3.64
   Ulocladium          0.82                                                    0.30--2.28                                               1.04                                                    0.37--2.95
   Wallemia            2.23[\*](#tfn6-ehp0113-001405){ref-type="table-fn"}     1.12--4.45                                               1.73                                                    0.80--3.75
   Yeasts              2.04[\*](#tfn6-ehp0113-001405){ref-type="table-fn"}     1.00--4.19                                               2.90[\*\*](#tfn7-ehp0113-001405){ref-type="table-fn"}   1.37--6.09
   Zygomycetes         0.80                                                    0.29--2.21                                               0.87                                                    0.31--2.44
   Total dust-borne    2.56[\*\*](#tfn7-ehp0113-001405){ref-type="table-fn"}   1.32--4.98                                               3.13[\*\*](#tfn7-ehp0113-001405){ref-type="table-fn"}   1.51--6.47

Controlling for water damage or mold or mildew in year 1, African-American ethnicity, maternal Alternaria IgE \> 0.35 U/mL, sex, and birth date in fall.

p \< 0.05;

p \< 0.01.

###### 

Multivariate Cox regression models of allergic rhinitis.

                                             Model 1[a](#tfn9-ehp0113-001405){ref-type="table-fn"}    Model 2[b](#tfn10-ehp0113-001405){ref-type="table-fn"}   Model 3[c](#tfn11-ehp0113-001405){ref-type="table-fn"}                                                                         
  ------------------------------------------ -------------------------------------------------------- -------------------------------------------------------- -------------------------------------------------------- ------------ -------------------------------------------------------- ------------
  Water damage or mold/mildew in year 1      1.66                                                     0.88--3.15                                               1.77                                                     0.94--3.34   1.66                                                     0.87--3.17
  Male sex                                   1.79                                                     0.97--3.29                                               1.88 [\*](#tfn12-ehp0113-001405){ref-type="table-fn"}    1.03--3.42   1.78                                                     0.97--3.28
  LRI ever in year 1                         1.58                                                     0.83--3.02                                               ---                                                      ---          1.62                                                     0.84--3.12
  Maternal IgE to Alternaria \> 0.35 U/mol   3.07[\*\*](#tfn13-ehp0113-001405){ref-type="table-fn"}   1.49--6.32                                               2.96[\*\*](#tfn13-ehp0113-001405){ref-type="table-fn"}   1.44--6.09   3.21[\*\*](#tfn13-ehp0113-001405){ref-type="table-fn"}   1.56--6.60
  Race (black vs. others)                    3.82[\*\*](#tfn13-ehp0113-001405){ref-type="table-fn"}   1.73--8.44                                               3.79[\*\*](#tfn13-ehp0113-001405){ref-type="table-fn"}   1.72--8.38   3.27[\*\*](#tfn13-ehp0113-001405){ref-type="table-fn"}   1.51--7.08
  Season of birth (Sep--Nov vs. others)      2.44[\*\*](#tfn13-ehp0113-001405){ref-type="table-fn"}   1.35--4.42                                               2.46[\*\*](#tfn13-ehp0113-001405){ref-type="table-fn"}   1.35--4.47   2.46[\*\*](#tfn13-ehp0113-001405){ref-type="table-fn"}   1.36--4.48
  Dust-borne Alternaria                      1.40                                                     0.61--3.23                                               1.52                                                     0.67--3.44   2.07                                                     0.98--4.37
  Dust-borne Aspergillus                     3.27[\*\*](#tfn13-ehp0113-001405){ref-type="table-fn"}   1.50--7.14                                               2.93[\*\*](#tfn13-ehp0113-001405){ref-type="table-fn"}   1.36--6.30   2.73[\*](#tfn12-ehp0113-001405){ref-type="table-fn"}     1.27--5.87
  Dust-borne Aureobasidium                   3.04[\*\*](#tfn13-ehp0113-001405){ref-type="table-fn"}   1.33--6.93                                               3.06[\*\*](#tfn13-ehp0113-001405){ref-type="table-fn"}   1.35--6.91   ---                                                      ---
  Dust-borne yeasts                          2.67[\*](#tfn12-ehp0113-001405){ref-type="table-fn"}     1.26--5.66                                               2.80[\*\*](#tfn13-ehp0113-001405){ref-type="table-fn"}   1.33--5.93   2.52[\*](#tfn12-ehp0113-001405){ref-type="table-fn"}     1.18--5.36

Abbreviations: ---, not included; LRI, lower respiratory infection.

Full multivariate model.

Multivariate model omitting any lower respiratory infection in year 1.

Multivariate model omitting dust-borne Aureobasidium.

p \< 0.05;

p \< 0.01.

[^1]: The authors declare they have no competing financial interests.
